ArticleFrontiers in neuroscience2026
Multimodal machine learning reveals neurobiological signatures of binge-type eating disorders.
Article in Frontiers in neuroscience, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
6 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Introduction: Binge-type eating disorders, including bulimia nervosa (BN) and binge eating disorder (BED), are associated with both shared and disorder-specific neurobiological mechanisms across brain, behavior, and physiology. A clearer distinction between shared mechanisms and disorder-specific alterations may advance our understanding of binge-type eating pathology. Methods: We applied a comprehensive multimodal machine learning framework to 110 participants (BN, BED, and age & weight matched controls), integrating task-based fMRI, intrinsic connectivity, voxel-based morphometry, neuropsychological assessments, and peripheral blood biomarkers. Both unimodal and multimodal machine learning models were trained to classify groups and to predict individual variation in symptom expression. Results: Functional brain connectivity achieved the highest accuracy for diagnostic classification and symptom prediction (with a mean balanced classification accuracy (bACC) of 68.7%), whereas task-based fMRI with disorder-specific food stimuli and peripheral blood biomarkers best distinguished BN from BED (mean bACC of 87%). Multimodal models did not generally outperform the best unimodal approaches, except from modest gains in a limited set of regression targets. Conclusions: These findings suggest that functional brain connectivity carries robust predictive information for transdiagnostic classification, whereas task-evoked activation patterns and peripheral biomarkers show stronger predictive utility for distinguishing BN from BED. Whether these modality-specific patterns reflect underlying neurobiological mechanisms remains to be established in future hypothesis-driven work. Identifying which modalities best represent shared vulnerability vs. symptom-type-dependent variation may help to provide a foundation for a more mechanistic understanding of these disorders.
Indexed as
Identifiers
What Socratic holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the Socratic graph.